In 2000 Admedus Vaccines, a University of Queensland (UQ) spin off company was founded, with the goal of developing vaccines to transform global health issues. Under the guidance of Professor Ian Frazer, AdmedusVaccines is developing world-first DNA vaccines for the treatment of various infectious diseases and cancers in humans.